Ad is loading...
GOSS
Price
$0.70
Change
+$0.04 (+6.06%)
Updated
Nov 22 closing price
117 days until earnings call
RVNC
Price
$3.84
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
100 days until earnings call
Ad is loading...

GOSS vs RVNC

Header iconGOSS vs RVNC Comparison
Open Charts GOSS vs RVNCBanner chart's image
Gossamer Bio
Price$0.70
Change+$0.04 (+6.06%)
Volume$1.79M
CapitalizationN/A
Revance Therapeutics
Price$3.84
Change-$0.00 (-0.00%)
Volume$683.35K
CapitalizationN/A
GOSS vs RVNC Comparison Chart
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVNC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GOSS vs. RVNC commentary
Nov 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Buy and RVNC is a StrongBuy.

COMPARISON
Comparison
Nov 25, 2024
Stock price -- (GOSS: $0.70 vs. RVNC: $3.73)
Brand notoriety: GOSS and RVNC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 196% vs. RVNC: 76%
Market capitalization -- GOSS: $157.63M vs. RVNC: $391.29M
GOSS [@Biotechnology] is valued at $157.63M. RVNC’s [@Biotechnology] market capitalization is $391.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $468.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileRVNC’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • RVNC’s FA Score: 0 green, 5 red.
According to our system of comparison, GOSS is a better buy in the long-term than RVNC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 3 TA indicator(s) are bullish while RVNC’s TA Score has 5 bullish TA indicator(s).

  • GOSS’s TA Score: 3 bullish, 5 bearish.
  • RVNC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RVNC is a better buy in the short-term than GOSS.

Price Growth

GOSS (@Biotechnology) experienced а -6.01% price change this week, while RVNC (@Biotechnology) price change was -10.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

GOSS is expected to report earnings on Mar 21, 2025.

RVNC is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVNC($391M) has a higher market cap than GOSS($158M). GOSS YTD gains are higher at: -23.770 vs. RVNC (-57.565). GOSS has higher annual earnings (EBITDA): -52.24M vs. RVNC (-269.98M). GOSS has more cash in the bank: 327M vs. RVNC (184M). GOSS has less debt than RVNC: GOSS (204M) vs RVNC (483M). RVNC has higher revenues than GOSS: RVNC (257M) vs GOSS (105M).
GOSSRVNCGOSS / RVNC
Capitalization158M391M40%
EBITDA-52.24M-269.98M19%
Gain YTD-23.770-57.56541%
P/E RatioN/AN/A-
Revenue105M257M41%
Total Cash327M184M178%
Total Debt204M483M42%
FUNDAMENTALS RATINGS
RVNC: Fundamental Ratings
RVNC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GOSSRVNC
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend about 1 month ago
83%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
View a ticker or compare two or three
Ad is loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVNC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MXHAX13.920.10
+0.72%
Empower Large Cap Value Inv II
JPIVX34.130.24
+0.71%
JPMorgan U.S. Applied Data Sci Val I
FCUEX19.740.13
+0.66%
NYLI PineStone U.S. Equity Class A
GDLFX18.700.03
+0.16%
Gotham Defensive Long 500 Institutional
TIIRX28.760.02
+0.07%
Nuveen Core Equity A

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with MEIP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
+4.66%
MEIP - GOSS
46%
Loosely correlated
-1.07%
CGEM - GOSS
45%
Loosely correlated
+2.62%
SYRE - GOSS
41%
Loosely correlated
+2.59%
APVO - GOSS
41%
Loosely correlated
+15.33%
VIR - GOSS
41%
Loosely correlated
+2.45%
More

RVNC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVNC has been loosely correlated with AXON. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RVNC jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVNC
1D Price
Change %
RVNC100%
-2.86%
AXON - RVNC
39%
Loosely correlated
+0.90%
HRMY - RVNC
39%
Loosely correlated
+2.53%
ABCL - RVNC
37%
Loosely correlated
+1.47%
GOSS - RVNC
35%
Loosely correlated
+4.66%
ARRY - RVNC
34%
Loosely correlated
+4.74%
More